Experience of terahertz therapy in benign prostatic hyperplasia combined with chronic abacterial prostatitis

Experience of terahertz therapy in benign prostatic hyperplasia combined with chronic abacterial prostatitis

Objective: to improve the treatment results of patients with benign prostatic hyperplasia (stage l-ll) accompanied with chronic abacterial prostatitis (category III A) by the use of terahertz therapy at frequencies of molecular spectrum of emission and absorption of nitric oxide 150,176-150,664 GHz....

Full description

Bibliographic Details
Main Authors:	Popkov V.M., Kirichuk V.F., Loyko V.S., Maslyakova G.N., Blyumberg B.l.
Format:	Article
Language:	Russian
Published:	Saratov State Medical University 2014-12-01
Series:	Саратовский научно-медицинский журнал
Subjects:	benign prostatic hyperplasia (BPH) chronic abacterial prostatitis (CAP) terahertz therapy (THZ-therapy)
Online Access:	http://www.ssmj.ru/system/files/2014_04_649-654.pdf

Similar Items

WHAT DOES ABACTERIAL PROSTATITITS HIDE?
by: А. А. Breusoff, et al.
Published: (2017-07-01)

IMPULSE BAROTHERAPY IN A COMPLEX TREATMENT OF PATIENT WITH CHRONIC ABACTERIAL PROSTATITIS AND ERECTILE DYSFUNCTION USING THE MKV-01 “IVAVITA” SYSTEM (CLINICAL CASE)
by: A. B. Dolgov, et al.
Published: (2018-08-01)

Cytokines profile changers after magnetic-heat-vibromassage in chronic abacterial prostatitis with erectile disfunction
by: D. G. Коren’kov, et al.
Published: (2016-11-01)

Rectal cream “Hem” (as suppositories) in treatment of chronic abacterial prostatitis
by: N. P. Naumov, et al.
Published: (2021-12-01)

MARKERS OF INFLAMMATION IN DIFFERENT FORMS OF CHRONIC ABACTERIAL PROSTATITIS
by: E. A. Chernogubova
Published: (2018-07-01)

EFFICIENCY OF LICOPID IN THE PATIENTS WITH CHRONIC ABACTERIAL PROSTATITIS COMPLICATED WITH FERTILITY DISORDERS
by: A. V. Semyonov, et al.
Published: (2014-07-01)

Non-steroid antiinflammatory drugs in therapy of chronic abacterial prostatitis/syndrome of chronic pelvic pain
by: A. D. Kaprin, et al.
Published: (2016-12-01)

Effect of Prostatilene® AC and Prostatilene® on the ejaculate level of antisperm antibodies in the treatment of patients with chronic abacterial prostatitis and concomitant reproductive dysfunctions
by: S. Kh. Al’-Shukri, et al.
Published: (2016-04-01)

Molecular Detection of Prostate Specific Antigen in Patients with Prostate Cancer or Benign Prostate Hyperplasia the First Investigation from Iran
by: L Andonian, et al.
Published: (2005-08-01)

Molecular Detection of Prostate Specific Antigen in Patients with Prostate Cancer or Benign Prostate Hyperplasia the First Investigation from Iran
by: L Andonian, et al.
Published: (2005-09-01)

Giant Benign Prostatic Hyperplasia in a Pakistani Patient
by: Zafaruddin Khan, et al.
Published: (2014-01-01)

Comparison of the rate of complications after TUEB and cystic prostatectomy in patients with benign prostatic hyperplasia
by: G. V. Bachurin
Published: (2013-08-01)

THE FACTORS ASSOCIATED WITH THE INCIDENCE OF BENIGN PROSTATIC HYPERPLASIA
by: sukron sukron
Published: (2022-07-01)

Bladder drainage and glandular epithelial morphometry of the prostate in benign prostatic hyperplasia with severe symptoms
by: Carlos A. Cury, et al.
Published: (2006-04-01)

Incidental Prostate Cancer in Patients Treated for Benign Prostatic Hyperplasia: Analysis from a Contemporary National Dataset
by: Eugenio Bologna, et al.
Published: (2024-03-01)

Incidental Prostate Cancer in Patients Treated for Benign Prostate Hyperplasia in the Period of 21 Years
by: Matea Pirša, et al.
Published: (2018-01-01)

Comparative analysis of resected prostate weight in diabetic and non-diabetic benign prostatic hyperplasia patients
by: Emadouddin Moudi, et al.
Published: (2017-02-01)

Possibilities of entomological drugs in the symptomatic and pathogenetic therapy of benign prostatic hyperplasia and chronic abacterial prostatitis
by: Z. A. Kadyrov, et al.
Published: (2020-11-01)

Association Between Prostate Zonal Volume and Erectile Dysfunction in Patients With Benign Prostatic Hyperplasia
by: Muhammed M. Qalawena, MD, et al.
Published: (2020-06-01)

Prostate diseases in Lagos, Nigeria: A histologic study with tPSA correlation
by: C C Anunobi, et al.
Published: (2011-01-01)

Chronic Prostatitis / Chronic Pelvic Pain Syndrome – problematic common disease. Current knowledge on etiology, diagnosis and treatments
by: Wojciech Żołyniak, et al.
Published: (2022-12-01)

The efficacy of biologically active peptides derived from prostate tissue of bulls, in the treatment of excretory-toxic infertility, complication of chronic abacterial prostatitis
by: O. A. Nikiforov
Published: (2014-10-01)

Bladder stone secondary to prostatic urethral lift (PUL) for benign prostatic hyperplasia (BPH)
by: JiHun Kang
Published: (2021-11-01)

Portal Hypertension Secondary to Benign Prostatic Hyperplasia
by: Mustafa Küçükyangöz, et al.
Published: (2022-03-01)

Antimicrobial peptides for treatment of patients with herpes virus-associated chronic prostatitis
by: E. V. Kulchavenya, et al.
Published: (2023-04-01)

Thermobalancing conservative treatment for moderate-to-low-degree lower urinary tract symptoms (LUTS) secondary to prostate enlargement
by: Simon Allen, et al.
Published: (2016-12-01)

Emerging Data on the Safety and Efficacy of Transurethral Water Vapour Therapy for Benign Prostatic Hyperplasia
by: Jones P, et al.
Published: (2021-05-01)

Review of the role of pyroptosis in benign prostatic hyperplasia in old males
by: CHEN Zixuan, et al.
Published: (2023-12-01)

A NEW PARADIGM IN TREATMENT OF CHRONIC PROSTATITIS AS PREVENTION OF DEVELOPMENT OF PROSTATIC HYPERPLASIA
by: Y. G. Alyaev, et al.
Published: (2022-12-01)

A Review of Prostate Organogenesis and a Role for iPSC-Derived Prostate Organoids to Study Prostate Development and Disease
by: Adriana Buskin, et al.
Published: (2021-12-01)

Prostatic disorders in acromegalic patients experience of a Brazilian center
by: Livia L. Correa, et al.
Published: (2013-06-01)

Effect of urinary retention on the levels of prostate specific antigen (PSA) and prostatic acid phosphatase (PAP) in prostatic disease
by: R Chawla, et al.
Published: (2003-01-01)

Applications of Vertebrate Models in Studying Prostatitis and Inflammation-Associated Prostatic Diseases
by: Joosje Bleeker, et al.
Published: (2022-07-01)

Prostate – Specific Antigen (Psa) as a Screening Tool for Benign Prostate Hyperplasia (Bph) and Prostate Cancer (Pca) in Sulaimani Province
by: Sirwan M. Muhammad, et al.
Published: (2013-09-01)

Prostatic artery embolization: Progress and prospect
by: Li Cui, et al.
Published: (2020-05-01)

Prognostic significance of epithelial/stromal caveolin‐1 expression in prostatic hyperplasia, high grade prostatic intraepithelial hyperplasia and prostatic carcinoma and its correlation with microvessel density
by: Dareen A. Mohammed, et al.
Published: (2017-03-01)

Body size throughout the life-course and incident benign prostatic hyperplasia-related outcomes and nocturia
by: Saira Khan, et al.
Published: (2021-03-01)

Can We Use the Silodosin as Second Line Treatment of Benign Prostate Hyperplasia?
by: Bekir Voyvoda, et al.
Published: (2021-09-01)

Incidence and Risk Factors of Post-Operative Depression in Patients Undergoing Transurethral Resection of Prostate for Benign Prostatic Hyperplasia
by: Zhu D, et al.
Published: (2021-11-01)

The effectiveness of electromagnetic terahertz radiation use in the treatment of patients with rapidly progressive periodontitis
by: Zelenova A.V., et al.
Published: (2015-12-01)